Search

Your search keyword '"Anwer, Faiz"' showing total 12 results
Start Over Author "Anwer, Faiz" Journal cureus
12 results on '"Anwer, Faiz"'

9. Impact of Storage Lesion on Post-transfusion Rise in Hemoglobin

Author

Sardar, Muhammad, primary, Shaikh, Nasreen, additional, Ansell, Jack, additional, Jacob, Aasems, additional, Yada, Srujana, additional, Kelly, David B, additional, Doraiswamy, Mohankumar, additional, Khan, Wahab J, additional, Anwer, Faiz, additional, and Eng, Margaret HH, additional

Published
2018
Full Text
View/download PDF

11. Role of High-dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Ewing's Sarcoma: A Case Report with Focused Review of Literature.

Author

Tenneti P, Zahid U, Sagar F, Usman M, and Anwer F

Abstract

We report a case of a patient with relapsed Ewing's sarcoma (ES). After receiving conventional chemotherapy (CC) and noticing chemosensitivity of the disease, we proceeded to give the patient two separate cycles of HDCT consisting of a melphalan/busulfan regimen in the first cycle and etoposide/melphalan in the second cycle. The patient proceeded to get an autologous stem cell transplant (ASCT) after each cycle of HDCT. Our patient, despite multiple poor prognostic factors, including advanced age and multiple sites of disease relapse, showed a one-year event-free survival. Relapsed ES is associated with a poor prognosis. No treatment regimen has yet been established as a standard of care in patients with relapsed ES. We conducted a focused literature review to assess the efficacy of high-dose chemotherapy (HDCT) followed by ASCT in patients with relapsed ES. Given the improved survival outcome with HDCT followed by ASCT in our patient, we propose that its role in relapsed ES needs further assessment through large prospective, randomized controlled studies., Competing Interests: The authors have declared that no competing interests exist.

Published
2018
Full Text
View/download PDF

12. Disease Milestones through Bibliometric Analysis of the Top 100 Cited Articles in Multiple Myeloma.

Author

Latif A, Kapoor V, Sipra QUAR, Malik SU, Bilal J, Bin Riaz I, and Anwer F

Abstract

Multiple myeloma (MM) accounts for 1.6% of all cancers and 5%-10% of all hematologic malignancies in the United States (US). Despite marked progress in disease management, it remains incurable with high rates of relapse. We conducted a bibliographic analysis on the Web of Science (WOS) from July 25, 2017 and July 29, 2017. Among the top 100 most-cited articles (1901-2012), the most cited article received 2404 citations and least cited article received 336 citations. Forty-four of 100 articles were published in journals with impact factors greater than 20. We observed that over the years, the focus of research has shifted from diagnosis, staging, and pathogenesis to better treatment outcomes. A subgroup analysis of the top 100 cited articles published in the last five years (2012-2017) demonstrated that several landmark studies, which will likely change the landscape of treating multiple myeloma, were not included in the top 100 list. Interestingly, most of these articles were focused on novel therapeutic agents. This bibliographic analysis provides a list of the 100 top-cited articles in multiple myeloma along with the captivating comprehension of the history and development in various aspects of disease processes. The landscape of this disease is rapidly evolving, and bibliometric studies such as the one presented provide a valuable tool that can highlight the important transitions in the field., Competing Interests: The authors have declared that no competing interests exist.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results